ArcherDX Growth, Revenue, Number of Employees and Funding

Overview

Location:
Boulder, CO USA
Total Funding:$95M
Industry:Biotech
Founded:2013
Lead Investor(s):Boulder Ventures, PBM Capital Group, LLC
Press

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • ArcherDX's estimated revenue is currently $36.3M per year.
  • ArcherDX received $35.0M in venture funding in March 2018.
  • ArcherDX's estimated revenue per employee is $227987
  • ArcherDX's total funding is $95M.

Employee Data

  • ArcherDX has 159 Employees.
  • ArcherDX grew their employee count by 43% last year.
  • ArcherDX currently has 32 job openings.

What Is ArcherDX?

ArcherDX, Inc., creates catalog and custom next-generation sequencing (NGS) assays that are purpose-built to identify mutations and gene fusions from clinical sample types. By combining novel enrichment chemistry, automated informatics and a user-friendly workflow, Archer products remove the bottlenecks associated with using next-gen sequencing in a translational setting.

keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals

159

Number of Employees

$36.3M

Revenue (est)

32

Current Jobs

43%

Employee Growth %

$95M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
MBio Diagnostic...
N/A320%
Mile High Labs
N/A950%$100M
GlobeImmune
N/A330%
Isolate Extract...
N/A360%
Biodesix
$19.1M14620%$182M
miRagen Therape...
$3.9M8019%public
Inscripta
N/A8989%$134.2M
ArcherDX
$36.3M15943%$95M
Clovis Oncology
$95.4M48021%$763.3M
Cerapedics
$10.5M5138%$112.3M

ArcherDX News

09/08/2019 - Immune Repertoire Sequencing Market – Survey On Potential Players 2028 | Atreca, Inc., ArcherDX, Inc.

For example, Archer Immunoverse B Cell Receptor (BCR) was launched by ArcherDX, Inc in 2017 to examine human B cell repertoire.

05/15/2019 - ArcherDX Announces Close of $60M Financing to Advance ...

BOULDER, Colo., May 15, 2019 /PRNewswire/ -- ArcherDX, Inc., a molecular technology company dedicated to developing breakthrough ...

03/05/2019 - ArcherDX Announces Expansion of Executive Leadership ...

BOULDER, Colo., March 5, 2019 /PRNewswire/ -- ArcherDX, Inc., a molecular technology company dedicated to developing breakthrough ...

ArcherDX Funding

DateAmountRoundLead InvestorsReference
2018-03-21$35.0MABoulder Ventures, Ltd.Article

ArcherDX Acquisitions

DateCompany NameAmountNotesReference
2019-01-31Baby Genes, IncArticle